01.05 - Abstract su rivista

01.05 - Abstract su rivista: [3081] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 41 a 60 di 3.081

SAT0300 SERUM FROM “EARLY” SYSTEMIC SCLEROSIS PATIENTS ALREADY INDUCES THE ALTERNATIVELY ACTIVATED MACROPHAGE PHENOTYPE (M2) IN CULTURED HUMAN MONOCYTES

2020-01-01 Soldano, S.; Tardito, S.; Paolino, S.; Patanè, M.; Gotelli, E.; Corallo, C.; Pizzorni, C.; Pacini, G.; Goegan, F.; Sulli, A.; Schenone, C.; Smith, V.; Cutolo, M.

SAT0301 CIRCULATING FIBROCYTES FROM SYSTEMIC SCLEROSIS PATIENTS AS POSSIBLE TARGET OF CTLA4-IG TREATMENT: AN IN VITRO STUDY

2020-01-01 Soldano, S.; Montagna, P.; Paolino, S.; Alessandri, E.; Pizzorni, C.; Pacini, G.; Goegan, F.; Sulli, A.; Schenone, C.; Smith, V.; Cutolo, M.

AB0168 NINTEDANIB (TYROSINE-KINASE INHIBITOR) INHIBITS THE TRANSITION OF CIRCULATING FIBROCYTES ISOLATED FROM SYSTEMIC SCLEROSIS PATIENTS INTO MYOFIBROBLASTS: AN IN VITROSTUDY

2020-01-01 Soldano, S.; Martinelli, G.; Tardito, S.; Paolino, S.; Patanè, M.; Gotelli, E.; Corallo, C.; Pizzorni, C.; Sulli, A.; Schenone, C.; Smith, V.; Cutolo, M.

POS0132 POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS INDUCED BY IMMUNE CHECKPOINT INHIBITORS: A SYSTEMATIC REVIEW AND META-ANALYSIS REVEALING KEY DIFFERENCES WITH THE IDIOPATHIC FORMS

2025-01-01 Hysa, E.; Casabella, A.; Gotelli, E.; Campitiello, R.; Genova, C.; Tanda, E. T.; Pizzorni, C.; Sulli, A.; Smith, V.; Cimmino, M. A.; Paolino, S.; Cutolo, M.

POS0568 Progressive microvascular abnormalities detectable overtime by nailfold videocapillaroscopy in long-COVID patients: a multicenter Italian investigation

2025-01-01 Gotelli, E.; Campitiello, R.; Pizzorni, C.; Sammorì, S.; Aitella, E.; Ginaldi, L.; De Martinis, M; Carubbi, F.; Di Ruscio, E.; Cuomo, G.; Martinelli, E.; Marrone, S.; De Angelis, R.; Giuggioli, D.; Guiducci, S.; Ingegnoli, F.; Riccieri, V.; Sebastiani, M.; Sulli, A.; Smith, V.; Cutolo, M.

POS1337 CLINICAL OUTCOMES OF METHOTREXATE TREATMENT FOR IMMUNE CHECKPOINT INHIBITOR-INDUCED ARTHRITIS IN CANCER PATIENTS: A RETROSPECTIVE LONGITUDINAL PILOT STUDY

2025-01-01 Hysa, E.; Casabella, A.; Iandolino, N.; Gotelli, E.; Genova, C.; Tanda, E. T.; Pizzorni, C.; Smith, V.; Sulli, A.; Cutolo, M.; Paolino, S.

POS0882 AMINAPHTONE LONG-TERM TREATMENT IN SYSTEMIC SCLEROSIS

2021-01-01 Sulli, A.; Gotelli, E.; Cere, A.; Hysa, E.; Pacini, G.; Pizzorni, C.; Paolino, S.; Cutolo, M.

AB0738 Do cosmetic silicone implants trigger systemic sclerosis? | Annals of the Rheumatic Diseases

2022-01-01 Lercara, A.; Sulli, A.; Pizzorni, C.; Gotelli, E.; Paolino, S.; Cere, A.; Cutolo, M.

POS0850 NAILFOLD CAPILLARY DILATIONS IN RAYNAUD'S PHENOMENON: QUANTIFYING A PREDICTIVE THRESHOLD FOR THE ‘SCLERODERMA PATTERN‘

2021-01-01 Pacini, G.; Pendolino, M.; Pizzorni, C.; Gotelli, E.; Sulli, A.; Carmisciano, L.; Paolino, S.; Smith, V.; Cutolo, M.

POS1382 AN OVERVIEW OF NAILFOLD CAPILLAROSCOPY IN ITALY: RESULTS FROM A NATIONAL SURVEY

2022-01-01 Ingegnoli, F.; Cornalba, M.; De Angelis, R.; Guiducci, S.; Giuggioli, D.; Pizzorni, C.; Riccieri, V.; Sebastiani, M.; Sulli, A.; Cutolo, M.

AB0057 IN VITRO EFFECT OF CTLA4-IGG ON M1-M2 SHIFT OF MACROPHAGES FROM RHEUMATOID ARTHRITIS PATIENTS

2021-01-01 Tardito, S.; Soldano, S.; Gotelli, E.; Montagna, P.; Paolino, S.; Smith, V.; Cutolo, M.

POS0583 ENGINEERED GLOVE TO EVALUATE THE SPEED OF THE HANDS' MOVEMENTS IN RHEUMATOID ARTHRITIS

2021-01-01 Patanè, M.; Carmisciano, L.; Hysa, E.; Gotelli, E.; Signori, A.; Smith, V.; Cutolo, M.

POS0815 ULTRASONOGRAPHY FOR DAY-TO-DAY CLINICAL USE: CONSTRUCTION OF A SIMPLE DISCRIMINATOR BETWEEN HEALTHY SKIN AND THICKENED SYSTEMIC SCLEROSIS SKIN

2024-01-01 Smith, V.; Berghen, N.; Hysa, E.; Vanhaecke, A.; Wallaert, S.; Gotelli, E.; Cutolo, M.

AB0739 Aminaphtone tolerability and safety in scleroderma patients: a four-year follow-up | Annals of the Rheumatic Diseases

2022-01-01 Cere, A.; Gotelli, E.; Lercara, A.; Pizzorni, C.; Paolino, S.; Alessandri, E.; Cutolo, M.; Sulli, A.

SAT0484 TRABECULAR BONE SCORE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

2020-01-01 Casabella, A.; Paolino, S.; Alessandri, E.; Smith, V.; Ruaro, B.; Pizzorni, C.; Sulli, A.; Cutolo, M.

POS0747 CORRELATIONS BETWEEN CAPILLARY DENSITY AND DEGREE OF SKIN PIGMENTATION IN HEALTHY CHILDREN ANALYSED BY NAILFOLD VIDEO CAPILLAROSCOPY

2023-01-01 Bergkamp, S.; Smith, V.; Kuijpers, T.; Cutolo, M.; Van Den Berg, J. M.; Schonenberg-Meinema, D.

AB0805 DESCRIPTION IN FLOW IN EARLY VERSUS CLINICALLY OVERT SYSTEMIC SCLEROSIS. LASER SPECKLE CONTRAST ANALYSIS: A DESCRIPTIVE STUDY ON THE PERIPHERAL BLOOD OF THE DIFFERENT SUBTYPES OF SYSTEMIC SCLEROSIS

2023-01-01 Smith, V.; Willems, S.; Du Four, T.; Wallaert, S.; Gotelli, E.; Cere, A.; Cutolo, M.

AB0092 CTLA4-Ig PROMOTES THE M1-M2 SHIFT IN CULTURED MACROPHAGES OF RHEUMATOID ARTHRITIS PATIENTS WITH ACTIVE DISEASE: IN VITRO STUDY

2022-01-01 Cutolo, M.; Tardito, S.; Gotelli, E.; Montagna, P.; Campitiello, R.; Paolino, S.; Pizzorni, C.; Sulli, A.; Smith, V.; Soldano, S.

AB1187 LONG-TERM SAFETY AND EFFICACY OF AMINAPHTONE IN SYSTEMIC SCLEROSIS PATIENTS WITH ACTIVE RAYNAUD’S PHENOMENON

2024-01-01 Sulli, A.; Campitiello, R.; Gotelli, E.; Cere, A.; Hysa, E.; Vojinovic, T.; Schenone, C.; Paolino, S.; Pizzorni, C.; Alessandri, E.; Cutolo, M.

AB0292 BONE MINERAL DENSITY (BMD), BONE TURNOVER MARKERS (BTMS) AND EVALUATION OF MUSCULOSKELETAL SYSTEM IN PATIENTS WITH DIFFERENTIATED THYROID CANCER UNDERGOING TSH SUPPRESSIVE THERAPY

2024-01-01 Casabella, A.; Paolino, S.; Vera, L.; Gay, S.; Restelli, M.; Ferone, D.; Sulli, A.; Hysa, E.; Cutolo, M.

Titolo	Data di pubblicazione	Autore(i)
SAT0300 SERUM FROM “EARLY” SYSTEMIC SCLEROSIS PATIENTS ALREADY INDUCES THE ALTERNATIVELY ACTIVATED MACROPHAGE PHENOTYPE (M2) IN CULTURED HUMAN MONOCYTES	1-gen-2020	Soldano, S.; Tardito, S.; Paolino, S.; Patanè, M.; Gotelli, E.; Corallo, C.; Pizzorni, C.; Pacini, G.; Goegan, F.; Sulli, A.; Schenone, C.; Smith, V.; Cutolo, M.
SAT0301 CIRCULATING FIBROCYTES FROM SYSTEMIC SCLEROSIS PATIENTS AS POSSIBLE TARGET OF CTLA4-IG TREATMENT: AN IN VITRO STUDY	1-gen-2020	Soldano, S.; Montagna, P.; Paolino, S.; Alessandri, E.; Pizzorni, C.; Pacini, G.; Goegan, F.; Sulli, A.; Schenone, C.; Smith, V.; Cutolo, M.
AB0168 NINTEDANIB (TYROSINE-KINASE INHIBITOR) INHIBITS THE TRANSITION OF CIRCULATING FIBROCYTES ISOLATED FROM SYSTEMIC SCLEROSIS PATIENTS INTO MYOFIBROBLASTS: AN IN VITROSTUDY	1-gen-2020	Soldano, S.; Martinelli, G.; Tardito, S.; Paolino, S.; Patanè, M.; Gotelli, E.; Corallo, C.; Pizzorni, C.; Sulli, A.; Schenone, C.; Smith, V.; Cutolo, M.
POS0132 POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS INDUCED BY IMMUNE CHECKPOINT INHIBITORS: A SYSTEMATIC REVIEW AND META-ANALYSIS REVEALING KEY DIFFERENCES WITH THE IDIOPATHIC FORMS	1-gen-2025	Hysa, E.; Casabella, A.; Gotelli, E.; Campitiello, R.; Genova, C.; Tanda, E. T.; Pizzorni, C.; Sulli, A.; Smith, V.; Cimmino, M. A.; Paolino, S.; Cutolo, M.
POS0568 Progressive microvascular abnormalities detectable overtime by nailfold videocapillaroscopy in long-COVID patients: a multicenter Italian investigation	1-gen-2025	Gotelli, E.; Campitiello, R.; Pizzorni, C.; Sammorì, S.; Aitella, E.; Ginaldi, L.; De Martinis, M; Carubbi, F.; Di Ruscio, E.; Cuomo, G.; Martinelli, E.; Marrone, S.; De Angelis, R.; Giuggioli, D.; Guiducci, S.; Ingegnoli, F.; Riccieri, V.; Sebastiani, M.; Sulli, A.; Smith, V.; Cutolo, M.
POS1337 CLINICAL OUTCOMES OF METHOTREXATE TREATMENT FOR IMMUNE CHECKPOINT INHIBITOR-INDUCED ARTHRITIS IN CANCER PATIENTS: A RETROSPECTIVE LONGITUDINAL PILOT STUDY	1-gen-2025	Hysa, E.; Casabella, A.; Iandolino, N.; Gotelli, E.; Genova, C.; Tanda, E. T.; Pizzorni, C.; Smith, V.; Sulli, A.; Cutolo, M.; Paolino, S.
POS0882 AMINAPHTONE LONG-TERM TREATMENT IN SYSTEMIC SCLEROSIS	1-gen-2021	Sulli, A.; Gotelli, E.; Cere, A.; Hysa, E.; Pacini, G.; Pizzorni, C.; Paolino, S.; Cutolo, M.
AB0738 Do cosmetic silicone implants trigger systemic sclerosis? \| Annals of the Rheumatic Diseases	1-gen-2022	Lercara, A.; Sulli, A.; Pizzorni, C.; Gotelli, E.; Paolino, S.; Cere, A.; Cutolo, M.
POS0850 NAILFOLD CAPILLARY DILATIONS IN RAYNAUD'S PHENOMENON: QUANTIFYING A PREDICTIVE THRESHOLD FOR THE ‘SCLERODERMA PATTERN‘	1-gen-2021	Pacini, G.; Pendolino, M.; Pizzorni, C.; Gotelli, E.; Sulli, A.; Carmisciano, L.; Paolino, S.; Smith, V.; Cutolo, M.
POS1382 AN OVERVIEW OF NAILFOLD CAPILLAROSCOPY IN ITALY: RESULTS FROM A NATIONAL SURVEY	1-gen-2022	Ingegnoli, F.; Cornalba, M.; De Angelis, R.; Guiducci, S.; Giuggioli, D.; Pizzorni, C.; Riccieri, V.; Sebastiani, M.; Sulli, A.; Cutolo, M.
AB0057 IN VITRO EFFECT OF CTLA4-IGG ON M1-M2 SHIFT OF MACROPHAGES FROM RHEUMATOID ARTHRITIS PATIENTS	1-gen-2021	Tardito, S.; Soldano, S.; Gotelli, E.; Montagna, P.; Paolino, S.; Smith, V.; Cutolo, M.
POS0583 ENGINEERED GLOVE TO EVALUATE THE SPEED OF THE HANDS' MOVEMENTS IN RHEUMATOID ARTHRITIS	1-gen-2021	Patanè, M.; Carmisciano, L.; Hysa, E.; Gotelli, E.; Signori, A.; Smith, V.; Cutolo, M.
POS0815 ULTRASONOGRAPHY FOR DAY-TO-DAY CLINICAL USE: CONSTRUCTION OF A SIMPLE DISCRIMINATOR BETWEEN HEALTHY SKIN AND THICKENED SYSTEMIC SCLEROSIS SKIN	1-gen-2024	Smith, V.; Berghen, N.; Hysa, E.; Vanhaecke, A.; Wallaert, S.; Gotelli, E.; Cutolo, M.
AB0739 Aminaphtone tolerability and safety in scleroderma patients: a four-year follow-up \| Annals of the Rheumatic Diseases	1-gen-2022	Cere, A.; Gotelli, E.; Lercara, A.; Pizzorni, C.; Paolino, S.; Alessandri, E.; Cutolo, M.; Sulli, A.
SAT0484 TRABECULAR BONE SCORE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS	1-gen-2020	Casabella, A.; Paolino, S.; Alessandri, E.; Smith, V.; Ruaro, B.; Pizzorni, C.; Sulli, A.; Cutolo, M.
POS0747 CORRELATIONS BETWEEN CAPILLARY DENSITY AND DEGREE OF SKIN PIGMENTATION IN HEALTHY CHILDREN ANALYSED BY NAILFOLD VIDEO CAPILLAROSCOPY	1-gen-2023	Bergkamp, S.; Smith, V.; Kuijpers, T.; Cutolo, M.; Van Den Berg, J. M.; Schonenberg-Meinema, D.
AB0805 DESCRIPTION IN FLOW IN EARLY VERSUS CLINICALLY OVERT SYSTEMIC SCLEROSIS. LASER SPECKLE CONTRAST ANALYSIS: A DESCRIPTIVE STUDY ON THE PERIPHERAL BLOOD OF THE DIFFERENT SUBTYPES OF SYSTEMIC SCLEROSIS	1-gen-2023	Smith, V.; Willems, S.; Du Four, T.; Wallaert, S.; Gotelli, E.; Cere, A.; Cutolo, M.
AB0092 CTLA4-Ig PROMOTES THE M1-M2 SHIFT IN CULTURED MACROPHAGES OF RHEUMATOID ARTHRITIS PATIENTS WITH ACTIVE DISEASE: IN VITRO STUDY	1-gen-2022	Cutolo, M.; Tardito, S.; Gotelli, E.; Montagna, P.; Campitiello, R.; Paolino, S.; Pizzorni, C.; Sulli, A.; Smith, V.; Soldano, S.
AB1187 LONG-TERM SAFETY AND EFFICACY OF AMINAPHTONE IN SYSTEMIC SCLEROSIS PATIENTS WITH ACTIVE RAYNAUD’S PHENOMENON	1-gen-2024	Sulli, A.; Campitiello, R.; Gotelli, E.; Cere, A.; Hysa, E.; Vojinovic, T.; Schenone, C.; Paolino, S.; Pizzorni, C.; Alessandri, E.; Cutolo, M.
AB0292 BONE MINERAL DENSITY (BMD), BONE TURNOVER MARKERS (BTMS) AND EVALUATION OF MUSCULOSKELETAL SYSTEM IN PATIENTS WITH DIFFERENTIATED THYROID CANCER UNDERGOING TSH SUPPRESSIVE THERAPY	1-gen-2024	Casabella, A.; Paolino, S.; Vera, L.; Gay, S.; Restelli, M.; Ferone, D.; Sulli, A.; Hysa, E.; Cutolo, M.

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 41 a 60 di 3.081

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext2819
reserved188
open74